Best of ASCO - 2014 Annual Meeting

 

Welcome

Autologous Stem Cell Transplantation for NHL, HD, or CLL

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

2018 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
A pilot study evaluating the impact of hospital hospitality houses (HHH) programs on the quality of life and mood of patients and their caregivers following hematopoietic stem cell transplant (HCT).

Maria Emma Torres

e19500

A retrospective analysis comparing efficacy of filgastrim-sndz versus filgastrim for autologous, peripheral stem cell mobilization in patients with multiple myeloma and lymphoma.

Derek Young

e19505

Clinical factors influencing engraftment in patients with non-Hodgkin lymphoma following autologous stem cell transplant.

William Paul Skelton

e19504

Impact of individual comorbidities on post-transplant outcomes for elderly patients with non-Hodgkin lymphoma (NHL).

Andrew Ip

e19509

Phase 1b safety and antitumor activity of PLM60 (pegylated liposomal mitoxantrone) in NHL.

Simon Li

e19503

Preexisting cardiovascular disease in patients undergoing hematopoietic stem cell transplantation.

Mohamed Khayata

e19501

Real world survival rates and healthcare utilization among SEER-Medicare patients treated with hematopoietic stem cell transplant (HSCT) for relapsed/refractory diffuse large b-cell lymphoma (RR-DLBCL).

Anna G. Purdum

e19502

The outcome of patients with non-chemosensitive relapsed and refractory DLBCL salvaged with radiation therapy followed by autologous stem cell transplant.

Joanna C. Yang

e19507